Liverpool School of Tropical Medicine (LSTM) has launched a spinout, iiDiagnostics, to enable industry engagement and commercial access to the world-leading diagnostics R&D capability and facilities at LSTM – supporting the discovery and development of innovative diagnostics with the aim of saving lives globally.
First steps
iiDiagnostics will build on the R&D activity being delivered through the LSTM-led consortium iiCON, the Infection Innovation Consortium, which supports the interface between industry and academia.
The spinout will create a new commercial conduit for industry to interact with the leading global diagnostic capability within LSTM. It will support co-innovation and partnership working, enhancing the discovery and delivery of new innovative diagnostics that will ease the global burden of disease.
Official comments
Professor Hilary Ranson, Dean of Research Culture & Integrity and Professor of Medical Entomology at LSTM and founder of LITE, said: “Building on the hugely successful collaborative model pioneered by iiCON, which supports world-leading R&D by enabling industry and academic co-innovation, we’re delighted to be launching iiDiagnostics to create a new platform to support effective commercial engagement with industry and better enable access to the world-leading research and facilities at LSTM.”
Professor Janet Hemingway, founding Director of iiCON, said: “Working to enable new platforms that will enable industry to access the world-leading R&D capability within our leading academic institutions is at the heart of iiCON’s ethos. We’re very pleased to be working with our lead partner, LSTM, on the formation of this new spinout, which will support academic and industry co-innovation – helping to fast-track innovative diagnostic solutions to patients and communities most in need across the globe.”
